logo
February 6 - 9, 2020 | Orlando

Workshop Details

Feb. 9, 8:00 AM - 8:45 AM EST
Saturday

The Scientific and Investment Potential of Cannabinoids

Cannabinoid interaction with the human endocannabinoid system has been recognized as providing many beneficial clinical and anecdotal health outcomes. Many countries are moving to legalize medical cannabis and estimates suggest that the global cannabis industry may be worth more than USD 146 Billion by 2025. Despite growing awareness of its medicinal value, the emerging legal cannabis industry has primarily focused on cultivation and basic consumer products; however, the real potential of this versatile plant remains substantially untapped. Jim DeMesa, MD, will discuss the vital role of the body's endocannabinoid system and use of cannabinoids to address pain, nausea, inflammation, sleep disorders, and neurological diseases through the application of science. In addition, he will discuss avenues to invest in the many opportunities that are emerging with this progressive global cannabis trend. 

speaker photo CANNABIS INVESTMENTS
Jim DeMesa, MD, MBA

Chief Executive Officer

Emerald Health Pharmaceuticals Inc.